Back to
UBS Group AG
HRTX30 quarters
Position history for
UBS Group AG's holdings in HERON THERAPEUTICS INC
Yes. Ubs holds 2,997,073 shares of HRTX (Heron Therapeutics), worth $1.3M, as of its Q2 2026 13F filing. It increased the position by 711,190 shares (+31.1%) from Q1 2026. Ubs has held HRTX in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$1.3M
Current Shares
3M
Total Value Change
-$110,250
Total Shares Change
+2.9M
Quarter-by-Quarter History
Other major holders of HRTX: FRANKLIN TEMPLETON INC